ACUSENSUS LIMITED (ACE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ACE

ACE - ACUSENSUS LIMITED

FNArena Sector : Transportation & Logistics
Year End: June
GICS Industry Group : Software & Services
Debt/EBITDA: 2.52
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.68

07 Oct
2025

0.280

OPEN

$1.59

20.00%

HIGH

$1.75

588,191

LOW

$1.51

TARGET
$2.05

+0.75 change from previous day

22.0% upside
OTHER COMPANIES IN THE SAME SECTOR
AIZ . AQZ . AVD . AZJ . BWN . BXB . CLX . ERD . KLS . KSC . LAU . NTD . QAN . QUB . SPZ . SST . THL . WTC .
FNARENA'S MARKET CONSENSUS FORECASTS
ACE: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx - 2.0 - 0.7 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 20212022202320242025
EPS Basic xxxxxxxxxxxx-2.0
DPS All xxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxx59.4 M
Book Value Per Share xxxxxxxxxxxx33.4
Net Operating Cash Flow xxxxxxxxxxxx8.3 M
Net Profit Margin xxxxxxxxxxxx-4.42 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 20212022202320242025
Return on Capital Employed xxxxxxxxxxxx-6.34 %
Return on Invested Capital xxxxxxxxxxxx-5.91 %
Return on Assets xxxxxxxxxxxx-4.29 %
Return on Equity xxxxxxxxxxxx-6.34 %
Return on Total Capital xxxxxxxxxxxx-8.83 %
Free Cash Flow ex dividends xxxxxxxxxxxx-5.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 20212022202320242025
Short-Term Debt xxxxxxxxxxxx3 M
Long Term Debt xxxxxxxxxxxx5 M
Total Debt xxxxxxxxxxxx8 M
Goodwill - Gross xxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxx21 M
Price To Book Value xxxxxxxxxxxx2.85

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 20212022202320242025
Capex xxxxxxxxxxxx15.5 M
Capex % of Sales xxxxxxxxxxxx26.11 %
Cost of Goods Sold xxxxxxxxxxxx56 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxx8 M
Research & Development xxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

09/10/2025

1

Speculative Buy

$2.05

22.02%

Acusensus secured its largest US contract worth US$22.6m with the Connecticut Department of Transportation for automated speed enforcement over five years.

Morgans notes the win validates the company's technology in the US and strengthens its position for future contracts. Based on the annualised contract value of US$4.4m, the broker expects the initial ramp up to lift incremental revenue by $3.3m in FY26.

This is expected to rise to $6.8m annually from FY27. The broker expects FY26 guidance to be in the $82-87m range.

The broker also notes progress in $25m in new bank funding, improving flexibility and reducing capital risk.

Speculative Buy. Target rises to $2.05 from $1.30 on lift in earnings forecasts and applying a premium to valuation.

This report was published Wednesday.

FORECAST
Morgans forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -0.70 cents.
Morgans forecasts a full year FY27 dividend of 0.00 cents and EPS of minus -1.80 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

02/09/2025

1

Buy

$1.65

-1.79%

Acusensus' FY25 result showed solid revenue growth of 20% y/y to $59m, in line with Canaccord Genuity's forecast. Opex grew 26% y/y to $22m, but that was due to investment into growth mainly through headcount increases.

Total contracted value rose 84% y/y to $376m, and the company now has 17 long-term contracts across Australia, NZ, UK and US. 

FY26 guidance is for $79-84m, above the broker's earlier estimate of $75m. The broker lifted FY26 EBITDA forecast by 14% and FY27 by 1%, driven by a stronger revenue growth outlook.

Target rises to $1.65 from $1.50. Buy retained.

FORECAST
Canaccord Genuity forecasts a full year FY26 EPS of minus -1.80 cents.
Canaccord Genuity forecasts a full year FY27 EPS of minus -1.40 cents.

ACE STOCK CHART